A series of 18 consecutive patients with growth hormone-secreting pituitary adenoma treated by surgery were analyzed retrospectively. Apart from an unusually high male-to-female ratio, the demographic data, clinical presentation, and endocrinological findings were similar to those reported by other authors. There were four (22%) microadenomas and 14 (78%) macroadenomas with a large intracranial extension in three patients and gross radiological evidence of invasion of surrounding structures in three others. The mean preoperative basal serum growth hormone level was 48.6 ± 45.4 ng/mL. The tumor resection was carried out via a transsphenoidal route in 15 cases and via frontotemporal craniotomy in the remaining three. One patient died from pulmonary embolism ten days after transcranial tumor resection. The mean postoperative basal growth hormone level was 10.0 ± 10.4 ng/mL. The growth hormone level decreased below 5 ng/mL in six of the 17 survivors (35%) directly after surgery. Nine patients received adjuvant postoperative treatment as follows: dopamine agonist in four, somatostatin analog in one, radiotherapy in one, and a combined drug and radiotherapy in three. The postoperative follow-up period ranged between two and 55 months (mean 28.6). At last follow-up examination, 10 (59%) patients had normalized their basal growth hormone level. Two patients developed postoperative anterior pituitary lobe insufficiency and a third had permanent diabetes insipidus.Acromegaly is a serious medical disorder resulting from the unrestrained secretion of growth hormone (GH). The long-term effects of sustained excess of GH on metabolism and cardiovascular system are deleterious and include diabetes mellitus, arterial hypertension, heart disease, as well as an increased risk of malignancy.1-3 The mortality associated with untreated or partially treated acromegaly is double to threefold the expected rate in healthy subjects matched for age. 4,5 Acromegaly may be caused by a variety of pathological conditions, but GH-secreting pituitary adenomas are by far the most common. 6 The medical literature is rich with reports covering various aspects of this lesion; 4,[7][8][9][10][11][12] however, published data about experiences with this tumor and its management in Saudi Arabia have been lacking entirely. This has prompted us to review all cases of GH-secreting pituitary adenomas which were operated upon in our institution during a period of 10 years and to compare our findings with the relevant data from the literature.
Material and MethodsDuring a ten-year period starting in October 1982, 18 consecutive patients with previously untreated growth hormone-secreting pituitary adenoma underwent surgical removal of their tumors at the Neurosurgical Division of King Khalid University Hospital. They constituted 20.5% of all cases of pituitary adenoma treated there during the same period. The diagnosis of a pituitary adenoma was confirmed in all cases with computed tomography (CT) scan and, more recently, magnetic resonance imaging (MRI). A de...